Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A, et-al. Global cancer statistics 2018: globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Ca A Cancer J Clin. 2018;68(6):394–424.
Shu T, Zhao D, Li B, Wang Y, Liu S, Li P, et al. Prognostic evaluation of postoperative adjuvant therapy for operable cervical cancer: 10 years’ experience of National Cancer Center in China. Chin J Cancer Res. 2017;29(6):510–20.
Article
PubMed
PubMed Central
Google Scholar
Baalbergen A, Veenstra Y, Stalpers L. Primary surgery versus primary radiotherapy with or without chemotherapy for early adenocarcinoma of the uterine cervix. Cochrane Database Syst. 2013;1:CD006248.
Google Scholar
Ryu SY, Kim MH, Nam BH, Lee TS, Song ES, Park CY, et al. Intermediate-risk grouping of cervical cancer patients treated with radical hysterectomy: a korean gynecologic oncology group study. Br J Cancer. 2014;110(2):278–85.
Article
CAS
PubMed
Google Scholar
Fujiwara H, Yokota H, Monk B, Treilleux I, Devouassoux-Shisheboran M, Davis A, et al. Gynecologic cancer intergroup (GCIG) consensus review for cervical adenocarcinoma. Int J Gynecol Cancer. 2014;24(9):S96–S101.
Article
PubMed
Google Scholar
Young RH, Clement PB. Endocervical adenocarcinoma and its variants: their morphology and differential diagnosis. Histopathology. 2002;41:185–207.
Article
CAS
PubMed
Google Scholar
Chan PG, Sung HY, Sawaya GF. Changes in cervical cancer incidence after three decades of screening US women less than 30 years old. Obstet Gynecol. 2003;102:765–73.
PubMed
Google Scholar
Vinh-Hung V, Bourgain C, Vlastos G, Gábor Cserni, Ridder, MD, Storme G, et al. Prognostic value of histopathology and trends in cervical cancer: a seer population study. BMC Cancer; 2007: 7(1), 164–0.
Mabuchi S, Okazawa M, Matsuo K, Kawano M, Suzuki O, Miyatake T, et al. Impact of histological subtype on survival of patients with surgically-treated stage ia2–iib cervical cancer: adenocarcinoma versus squamous cell carcinoma. Gynecol Oncol. 2012;127(1):114–20.
Article
PubMed
Google Scholar
National Comprehensive Cancer Network NCCN Clinical Practice Guidelines in Oncology, Cervical Cancer Version 2 (2015).
Reis RD, Frumovitz M, Milam MR, Capp E, Sun CC, Coleman RL, et al. Adenosquamous carcinoma versus adenocarcinoma in early-stage cervical cancer patients undergoing radical hysterectomy: an outcomes analysis. Gynecol Oncol. 2007;107(3):458–63.
Article
PubMed
Google Scholar
Lai CH, Chou HH, Chang CJ, Wang CC, Hsueh S, Huang YT, et al. Clinical implications of human papillomavirus genotype in cervical adeno-adenosquamous carcinoma. China J Modern Med. 2013;49(3):633–41.
Google Scholar
Kasamatsu T, Onda T, Sawada M, Kato T, Ikeda S, Sasajima Y, et al. Radical hysterectomy for FIGO stage I–IIB adenocarcinoma of the uterine cervix. Br J Cancer. 2009;100:1400–5.
Article
CAS
PubMed
PubMed Central
Google Scholar
Park JY, Kim DY, Kim JH, Kim YM, Kim YT, Nam JH. Outcomes after radical hysterectomy in patients with early-stage adenocarcinoma of uterine cervix. Br J Cancer. 2010;102:1692–8.
Article
CAS
PubMed
PubMed Central
Google Scholar
Mabuchi S, Suzuki O, Kamiura S, Ogawa K, Kimura T, Okazawa M, et al. Impact of the addition of concurrent chemotherapy to pelvic radiotherapy in surgically treated stage IB1-IIB cervical cancer patients with intermediate-risk or high-risk factors: a 13-year experience. Int J Gynecol Cancer. 2013;23(3):567–75.
Article
PubMed
Google Scholar
Lee KBM, Lee JM, Park CY, Lee KB, Cho HY, Ha SY. What is the difference between squamous cell carcinoma and adenocarcinoma of the cervix? A matched case–control study. Int J Gynecol Cancer. 2006;16:1569–73.
Article
PubMed
Google Scholar
Chen JL, Cheng JC, Kuo SH, Chen CA, Lin MC, Huang CY. Outcome analysis of cervical adenosquamous carcinoma compared with adenocarcinoma. Acta Obstet Gynecol Scand. 2012;91:1158–66.
Article
PubMed
Google Scholar
Baek MH, Park JY, Kim D, Suh DS, Nam JH. Comparison of adenocarcinoma and adenosquamous carcinoma in patients with early-stage cervical cancer after radical surgery. Gynecologic Oncol. 2014;135(3):462–7.
Lee JY, Lee C, Hahn S, Kim MA, Kim HS, Chung HH, et al. Prognosis of Adenosquamous carcinoma compared with adenocarcinoma in uterine cervical Cancer: a systematic review and meta-analysis of observational studies. Int J Gynecol Cancer Official J Int Gynecol Cancer Soc. 2014;24(2):289.
Article
Google Scholar
Farley JH, Hickey KW, Carlson JW, Rose GS, Kost ER, Harrison TA. Adenosquamous histology predicts a poor outcome for patients with advanced-stage, but not early-stage, cervical carcinoma. Cancer. 2003;97:2196–202.
Article
PubMed
Google Scholar
Nakanishi T, Ishikawa H, Suzuki Y, Inoue T, Nakamura S, Kuzuya K. A comparison of prognoses of pathologic stage Ib adenocarcinoma and squamous cell carcinoma of the uterine cervix. Gynecol Oncol. 2000;79:289–93.
Article
CAS
PubMed
Google Scholar
Galic V, Herzog TJ, Lewin SN, Neugut AI, Burke WM, Lu YS, et al. Prognostic significance of adenocarcinoma histology in women with cervical cancer. Gynecol Oncol. 2012;125(2):287–91.
Article
PubMed
Google Scholar
Irie T, Kigawa J, Minagawa Y, Itamochi H, Sato S, Akeshima R, et al. Prognosis and clinicopathological characteristics of Ib-IIb adenocarcinoma of the uterine cervix in patients who have had radical hysterectomy. Eur J Surg Oncol. 2000;26:464–7.
Article
CAS
PubMed
Google Scholar
Huang YT, Wang CC, Tsai CS, Lai CH, Chang TC, Chou HH, et al. Long-term outcome and prognostic factors for adenocarcinoma/adenosquamous carcinoma of cervix after definitive radiotherapy. Int J Radiat Oncol Biol Phys. 2011;80:429–36.
Article
PubMed
Google Scholar
Gien LT, Beauchemin MC, Thomas G. Adenocarcinoma: a unique cervical cancer. Gynecol Oncol. 2010;116:140–6.
Article
CAS
PubMed
Google Scholar
Sherman ME, Wang SS, Carreon J, Devesa SS. Mortality trends for cervical squamous and adenocarcinoma in the United States. Cancer. 2005;103(6):1258–64.
Article
PubMed
Google Scholar
Castellsagué X, Díaz M, De Sanjosé S, Muñoz N, Herrero R, Franceschi S, et al. Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention. J Natl Cancer Inst. 2006;98:303–15.
Article
PubMed
Google Scholar
Sasieni P, Adams J. Changing rates of adenocarcinoma and adenosquamous carcinoma of the cervix in England. Lancet. 2001;357:1490–3.
Article
CAS
PubMed
Google Scholar
Huang CY, You SL, Chen CJ, Cheng WF, Luo HC, Hsieh CY. Incidence of cervical cancer and age-specific survival of small cell cervical carcinoma in Taiwan. Acta Obstet Gynecol Scand. 2011;90:1342–9.
Article
PubMed
Google Scholar
Noh JM, Park W, Kim YS, Kim JY, Kim HJ, Kim J, et al. Comparison of clinical outcomes of adenocarcinoma and adenosquamous carcinoma in uterine cervical cancer patients receiving surgical resection followed by radiotherapy: a multicenter retrospective study (KROG 13-10). Gynecol Oncol. 2014;132(3):618–23.
Article
PubMed
Google Scholar
Chen JL‐Y, Cheng JC‐H, Kuo S‐H, Chen C‐A, Lin M‐C, Huang C‐Y. Outcome analysis of cervical adenosquamous carcinoma compared withadenocarcinoma[J]. Acta Obstetricia Et Gynecologica Scandinavica, 2012; 91(10):1158–1166.
Davelaar EM, Lande JVD, Mensdorff-Pouilly SV, Blankenstein MA, Kenemans PA. Combination of serum tumor markers identifies high-risk patients with early-stage squamous cervical Cancer. Tumor Biol. 2008;29(1):9–17.
Article
CAS
Google Scholar
Reesink-Peters N, van der Velden J, ten Hoor KA, Boezem HM, de Vries EGE, Schilthuis MS, Mourits MJE, Nijman HW, Aalders JG, Hollema H, Pras E, Duk JM, van der Zee AGJ. Preoperative serum squamous cell carcinoma antigen levels in clinical decision making for patients with early-stage cervical cancer. J Clin Oncol. 2005;23:1455–62.
Article
PubMed
Google Scholar
Nakamura K, Kitahara Y, Satoh T, Takei Y, Takano M, Nagao S, et al. Analysis of the effect of adjuvant radiotherapy on outcomes and complications after radical hysterectomy in FIGO stage IB1 cervical cancer patients with intermediate risk factors (GOTIC study). Gynecol Oncol. 2016;14(1):61–2.
Google Scholar
Saigo PE, Cain JM, Kim WS, Gaynor JJ, Johnson K, Jr LJ, et al. prognostic factors in adenocarcinoma of the uterine cervix. Cancer. 2004; 92(1):262–267.
Wang SS, Sherman ME, Silverberg SG, Carreon JD, Lacey JV Jr, Zaino R, et al. Pathological characteristics of cervical adenocarcinoma in a multi-center US-based study. Gynecol Oncol. 2006;103:541–6.
Article
PubMed
Google Scholar
Twu NF, Ou YC, Liao CI, Chang WY, Yang LY, Tang YH, et al. Prognostic factors and adjuvant therapy on survival in early-stage cervical adenocarcinoma/adenosquamous carcinoma after primary radical surgery: a Taiwanese gynecologic oncology group (TGOG) study. Surg Oncol. 2016;25:229–35.
Article
PubMed
Google Scholar
Lea JS, Coleman RL, Garner EO, Duska LR, Miller DS, Schorge JO. Adenosquamous histology predicts poor outcome in low-risk stage IB1 cervical adenocarcinoma. Gynecol Oncol. 2003;91:558–62.
Article
PubMed
Google Scholar
Lee KB, Lee JM, Ki KD, Lee SK, Park CY, Ha SY. Comparison of adjuvant chemotherapy and radiation in patients with intermediate risk factors after radical surgery in FIGO stage IB-IIA cervical cancer. Int J Gynecol Cancer. 2008;18:1027–31.
Article
PubMed
Google Scholar
Takekuma M, Kasamatsu Y, Kado N, et al. Adjuvant chemotherapy versus concurrent chemoradiotherapy for high-risk cervical cancer after radical hysterectomy and systematic lymphadenectomy. Int J Clin Oncol. 2016;21:741–7.
Article
CAS
PubMed
Google Scholar